These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21595284)

  • 1. [Association between polymorphisms of TCF7L2 and type 2 diabetes with special reference to incretin action].
    Enya M; Horikawa Y; Takeda J
    Nihon Rinsho; 2011 May; 69(5):930-6. PubMed ID: 21595284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
    Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
    Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
    Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
    Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: Villareal et al. (2009) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes;59:479-485.
    Knop FK
    Diabetes; 2010 Jun; 59(6):e4; author reply e5-6. PubMed ID: 20508220
    [No Abstract]   [Full Text] [Related]  

  • 5. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S; Ostenson CG; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.
    Nauck MA
    Am J Med; 2011 Jan; 124(1 Suppl):S3-18. PubMed ID: 21194578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
    Saxena R; Gianniny L; Burtt NP; Lyssenko V; Giuducci C; Sjögren M; Florez JC; Almgren P; Isomaa B; Orho-Melander M; Lindblad U; Daly MJ; Tuomi T; Hirschhorn JN; Ardlie KG; Groop LC; Altshuler D
    Diabetes; 2006 Oct; 55(10):2890-5. PubMed ID: 17003358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
    Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T
    Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
    Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
    Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans.
    Lehman DM; Hunt KJ; Leach RJ; Hamlington J; Arya R; Abboud HE; Duggirala R; Blangero J; Göring HH; Stern MP
    Diabetes; 2007 Feb; 56(2):389-93. PubMed ID: 17259383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
    Pearson ER; Donnelly LA; Kimber C; Whitley A; Doney AS; McCarthy MI; Hattersley AT; Morris AD; Palmer CN
    Diabetes; 2007 Aug; 56(8):2178-82. PubMed ID: 17519421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
    Jin T; Liu L
    Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of incretin on diabetes mellitus.
    Sanusi H
    Acta Med Indones; 2009 Oct; 41(4):205-12. PubMed ID: 20737753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.
    Knop FK; Holst JJ; Vilsbøll T
    IDrugs; 2008 Jul; 11(7):497-501. PubMed ID: 18600596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies for the treatment of type 2 diabetes mellitus based on incretin action.
    Gallwitz B
    Minerva Endocrinol; 2006 Jun; 31(2):133-47. PubMed ID: 16682937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.
    Thorsby PM; Midthjell K; Gjerlaugsen N; Holmen J; Hanssen KF; Birkeland KI; Berg JP
    Scand J Clin Lab Invest; 2009; 69(2):282-7. PubMed ID: 18972257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor 7-like 2-gene polymorphism is related to fasting C peptide in latent autoimmune diabetes in adults (LADA).
    Szepietowska B; Moczulski D; Wawrusiewicz-Kurylonek N; Grzeszczak W; Gorska M; Szelachowska M
    Acta Diabetol; 2010 Mar; 47(1):83-6. PubMed ID: 19533015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.